Hui Cheng

1.6k total citations · 1 hit paper
72 papers, 1.1k citations indexed

About

Hui Cheng is a scholar working on Molecular Biology, Hematology and Oncology. According to data from OpenAlex, Hui Cheng has authored 72 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Molecular Biology, 28 papers in Hematology and 10 papers in Oncology. Recurrent topics in Hui Cheng's work include Acute Myeloid Leukemia Research (16 papers), Hematopoietic Stem Cell Transplantation (10 papers) and RNA modifications and cancer (6 papers). Hui Cheng is often cited by papers focused on Acute Myeloid Leukemia Research (16 papers), Hematopoietic Stem Cell Transplantation (10 papers) and RNA modifications and cancer (6 papers). Hui Cheng collaborates with scholars based in China, Canada and United Kingdom. Hui Cheng's co-authors include Jinjin Shi, Kaixiang Zhang, Junjie Liu, Zhenzhong Zhang, Jianmin Wang, Weimin Nie, Xinyuan Yang, Jianmin Yang, Xiu Zhao and Xiaoxia Hu and has published in prestigious journals such as Advanced Materials, Blood and ACS Nano.

In The Last Decade

Hui Cheng

63 papers receiving 1.1k citations

Hit Papers

Physiologically Inspired Mucin Coated Escherichia coli Ni... 2022 2026 2023 2024 2022 40 80 120
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Physiologically Inspired Mucin Coated Escherichia coli Nissle 1917 Enhances Biotherapy by Regulating the Pathological Microenvironment to Improve Intestinal Colonization
    2022 142 citations Xinyuan Yang, Jiali Yang et al. ACS Nano profile →

Peers

Hui Cheng
Jinan Li China
Kelly E. Johnson United States
Xiaodong Feng United States
Sung‐Ho Kook South Korea
Per Fogelstrand Sweden
Xiaohong Zhang China
Liping Teng China
Jorge Martı́nez Chile
Laleh Shariati Iran
Seyed Mahdi Nassiri Iran
Jinan Li China
Hui Cheng
Citations per year, relative to Hui Cheng Hui Cheng (= 1×) peers Jinan Li

Countries citing papers authored by Hui Cheng

Since Specialization
Citations

This map shows the geographic impact of Hui Cheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hui Cheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hui Cheng more than expected).

Fields of papers citing papers by Hui Cheng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hui Cheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hui Cheng. The network helps show where Hui Cheng may publish in the future.

Co-authorship network of co-authors of Hui Cheng

This figure shows the co-authorship network connecting the top 25 collaborators of Hui Cheng. A scholar is included among the top collaborators of Hui Cheng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hui Cheng. Hui Cheng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cheng, Hui, Li Chen, & Chongmei Huang. (2025). Advances of signal transducer and activator of transcription 3 inhibitors in acute myeloid leukemia (Review). Oncology Letters. 29(3). 134–134. 1 indexed citations
2.
3.
Cheng, Hui, et al.. (2025). The global burden, trends, and inequalities of HIV/AIDS: a multicountry observational analysis. BMC Infectious Diseases. 25(1). 1259–1259.
4.
Wang, Ziwei, Hui Cheng, Yan Zhang, et al.. (2024). Anti-CD4 monoclonal antibody prevents chronic graft-versus-host disease in mice by inducing immune tolerance of CD8+ T cells and alleviating thymus injury. Frontiers in Immunology. 15. 1460687–1460687. 1 indexed citations
5.
Tang, Yujin, et al.. (2024). MADS-box BSISTER transcription factors regulate stilbenes biosynthesis in grapes by directly binding to the promoter of STS48. International Journal of Biological Macromolecules. 288. 138625–138625. 1 indexed citations
6.
Zhao, Xiu, Hui Cheng, Weimin Nie, et al.. (2023). Regulating Photosensitizer Metabolism with DNAzyme-Loaded Nanoparticles for Amplified Mitochondria-Targeting Photodynamic Immunotherapy. ACS Nano. 17(14). 13746–13759. 35 indexed citations
7.
Liu, Lulu, et al.. (2023). Hydrogel-based dressings designed to facilitate wound healing. Materials Advances. 5(4). 1364–1394. 74 indexed citations
8.
Cheng, Hui, Dongdong Chen, Lin Chen, et al.. (2023). Research on Key points of escalator braking Safety Performance detection method. Advances in Engineering Technology Research. 5(1). 70–70. 1 indexed citations
9.
Sun, Chunyan, Guangxun Gao, Fuling Zhou, et al.. (2023). Interim Results of the Launch Study-a Multicenter, Open-Label Study of Selinexor, Dexamethasone and Chemotherapy Drugs in Relapsed/ Refractory Multiple Myeloma. Blood. 142(Supplement 1). 4763–4763. 1 indexed citations
10.
Shi, Jinjin, Weimin Nie, Xiu Zhao, et al.. (2022). An Intracellular Self‐Assembly‐Driven Uninterrupted ROS Generator Augments 5‐Aminolevulinic‐Acid‐Based Tumor Therapy. Advanced Materials. 34(30). e2201049–e2201049. 44 indexed citations
11.
Yang, Xinyuan, Jiali Yang, Zihan Ye, et al.. (2022). Physiologically Inspired Mucin Coated Escherichia coli Nissle 1917 Enhances Biotherapy by Regulating the Pathological Microenvironment to Improve Intestinal Colonization. ACS Nano. 16(3). 4041–4058. 142 indexed citations breakdown →
12.
Chen, Xiaowen, Yixin Chen, Min Zhang, et al.. (2022). HucMSC exosomes promoted imatinib-induced apoptosis in K562-R cells via a miR-145a-5p/USP6/GLS1 axis. Cell Death and Disease. 13(1). 92–92. 29 indexed citations
13.
14.
Zhao, Xiu, Kaixiang Zhang, Yiyang Wang, et al.. (2022). Intracellular Self‐Assembly Driven Nucleus‐Targeted Photo‐Immune Stimulator with Chromatin Decompaction Function for Robust Innate and Adaptive Antitumor Immunity. Advanced Functional Materials. 32(17). 84 indexed citations
15.
Zhang, Yimin, Haihui Gu, Qi Chen, et al.. (2019). Low Platelet Counts at Diagnosis Predict Better Survival for Patients with Intermediate-Risk Acute Myeloid Leukemia. Acta Haematologica. 143(1). 9–18. 18 indexed citations
16.
Qiu, Huiying, Shenglan Gong, Lili Xu, et al.. (2018). MYD88 L265P mutation promoted malignant B cell resistance against T cell-mediated cytotoxicity via upregulating the IL-10/STAT3 cascade. International Immunopharmacology. 64. 394–400. 9 indexed citations
17.
Cheng, Hui, et al.. (2017). Microarray profiling and co-expression network analysis of the lncRNAs and mRNAs associated with acute leukemia in adults. Molecular BioSystems. 13(6). 1102–1108. 13 indexed citations
18.
Gao, Lei, Huiying Qiu, Chongmei Huang, et al.. (2015). Mouse bone marrow-derived mesenchymal stem cells inhibit leukemia/lymphoma cell proliferation in vitro and in a mouse model of allogeneic bone marrow transplant. International Journal of Molecular Medicine. 36(1). 139–149. 34 indexed citations
19.
Lü, Shuqing, et al.. (2015). High expression of neuroguidin increases the sensitivity of acute myeloid leukemia cells to chemotherapeutic drugs. Journal of Hematology & Oncology. 8(1). 11–11. 1 indexed citations
20.
Li, Lili, Jianmin Wang, Weiping Zhang, et al.. (2011). Value of circulating galactomannan screening for early diagnosis of invasive aspergillosis in hematological patients. 20(7). 418–421. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jinan Li Breakdown of academic impact, for papers by Kelly E. Johnson Breakdown of academic impact, for papers by Xiaodong Feng Breakdown of academic impact, for papers by Sung‐Ho Kook Breakdown of academic impact, for papers by Per Fogelstrand Breakdown of academic impact, for papers by Xiaohong Zhang Breakdown of academic impact, for papers by Liping Teng Breakdown of academic impact, for papers by Jorge Martı́nez Breakdown of academic impact, for papers by Laleh Shariati Breakdown of academic impact, for papers by Seyed Mahdi Nassiri
Rankless by CCL
2026